Achieve Life Sciences (ACHV) director files Form 3 reporting zero share ownership

Rhea-AI Filing Summary

Achieve Life Sciences director reports no holdings in initial filing. Director Lucian Iancovici filed a Form 3 as an insider of Achieve Life Sciences, Inc. and reported that he has no securities beneficially owned, with total direct holdings of 0 shares following the reported position.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Iancovici Lucian

Role null

Type	Security	Shares	Price	Value
holding	No securities beneficially owned	--	--	--

Holdings After Transaction: No securities beneficially owned — 0 shares (Direct, null)

Footnotes (1)

Key Figures

Total shares owned: 0 shares Transaction entries: 1 holding entry

2 metrics

Total shares owned 0 shares Total shares following reported position for director

Transaction entries 1 holding entry Initial Form 3 disclosure with no securities beneficially owned

Key Terms

Form 3, beneficially owned, direct ownership

3 terms

Form 3 regulatory

"Director Lucian Iancovici filed a Form 3 as an insider"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficially owned financial

"security_title: "No securities beneficially owned""

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

direct ownership financial

"ownership_type: "direct", ownership_code: "D""

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Iancovici Lucian

(Last) (First) (Middle)

C/O TPG INC.

301 COMMERCE STREET, SUITE 3300

(Street)

FORT WORTH TEXAS 76102

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/17/2026

3. Issuer Name and Ticker or Trading Symbol
ACHIEVE LIFE SCIENCES, INC. [ ACHV ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
No securities beneficially owned	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Lucian Iancovici	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the ACHV Form 3 filing by Lucian Iancovici show?

The Form 3 shows that director Lucian Iancovici currently reports no securities beneficially owned in Achieve Life Sciences, Inc., with total direct holdings of 0 shares following the reported position, as required when someone becomes a reporting insider.

Does the ACHV Form 3 report any buy or sell transactions?

No buy or sell transactions are reported. The filing lists a holding entry with the title “No securities beneficially owned” and shows 0 shares owned following the reported position, indicating only an initial disclosure of status rather than trading activity.

How many ACHV shares does director Lucian Iancovici own according to Form 3?

According to the Form 3, director Lucian Iancovici reports ownership of 0 shares of Achieve Life Sciences, Inc. The security title is listed as “No securities beneficially owned,” and total shares following the reported position are 0.0000 under direct ownership.

What is the ownership type disclosed in the ACHV Form 3?

The filing indicates direct ownership with an ownership code of “D.” Despite this direct ownership type, the position shows 0.0000 total shares following the reported status and a security title of “No securities beneficially owned” for the insider.

Are there any derivative securities reported in the ACHV Form 3?

No derivative securities are reported. The derivativeSummary section is empty, and the Form 3 only includes a single holding entry stating “No securities beneficially owned,” with no options, warrants, or other derivative positions listed for the reporting person.